BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Neuland Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
524558
ISIN Demat
INE794A01010
Book Value (Rs)
1453.5915229
NSE Symbol
NEULANDLAB
Divident Yield %
0.16
Market Cap
(Rs In Cr.)
27,584
P/E (TTM)
76.57
EPS (TTM)
280.77
Face Value
(Rs)
10
Back
Neuland Laboratories consolidated net profit rises 962.37% in the June 2026 quarter
05-Aug-26   Hrs IST

Net profit of Neuland Laboratories rose 962.37% to Rs 147.67 crore in the quarter ended June 2026 as against Rs 13.90 crore during the previous quarter ended June 2025. Sales rose 119.16% to Rs 641.58 crore in the quarter ended June 2026 as against Rs 292.75 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales641.58292.75 119
OPM %34.7411.78 -
PBDT224.4137.76 494
PBT197.8517.57 1026
NP147.6713.90 962

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)